K
Krankengymnastik+Massage
● Website: krankengymnastik.de
Business Health Check
Free comprehensive assessment for Krankengymnastik+Massage
16
Critical
Financial Health0/100
Company Size0/100
Growth Potential0/100
Stability & Risk60/100
Data Completeness35/100
Monitor Krankengymnastik+Massage
Get real-time alerts when this company's health score changes. Track competitors, suppliers, and clients.
Try SCALA OS →
🔔 Get notified when this score changes
Free. No spam. Unsubscribe anytime.
💼
Manage this company in your CRM
Import into S.C.A.L.A. CRM with AI agent SARA. From €97/mo.
Risk Overview
● Revenue: No data
● Profitability: Unknown
● Status: active
Key People
Executive data not available. Get Enterprise Report →
Corporate Structure
Corporate group data requires LEI. Get Enterprise Report →
Ownership
Detailed ownership available in Get Enterprise Report →
Top Competitors
Companies in the same sector and revenue range
| Company | Revenue | Employees | Score |
|---|---|---|---|
| Krankengymnastik+Massage | N/A | N/A | N/A |
| schaeffler américa del sur | > €1B | 1,000+ | 80 |
| Volkswagen Commercial Vehicles | > €1B | 1,000+ | 80 |
| KfW | > €1B | 1,000+ | 80 |
| renaud laurent, manager iad france | > €1B | 1,000+ | 80 |
| goldschmaus gruppe | > €1B | 1,000+ | 80 |
Certifications & Standards
No certifications on record. Claim this profile to add certifications (ISO 9001, ISO 14001, SOC 2, etc.).
Credit Worthiness
Fair
Acceptable financial standing
Latest News
Loading...
Company Details
| Address | Scheerstädter Weg 11, 36456 |
| Source | osm_geofabrik |
Website preview — krankengymnastik.de
Similar Companies in Barchfeld-Immelborn
schaeffler américa del sur €2.4B
Volkswagen Commercial Vehicles €3.8B
KfW €4.0B
renaud laurent, manager iad france €1.3B
goldschmaus gruppe €1.2B
xella international €1.9B
Feneberg Lebensmittel GmbH €1.5B
autovision gmbh (ein unternehmen im volkswagen konzern) €3.8B
unser heimatbäcker holding gmbh/lila bäcker €1.2B
daimler españa €3.8B
tum universitätsklinikum klinikum rechts der isar €1.3B
coalesce vanderbilt - meharry center of excellence in sickle cell disease €3.3B